Compass is getting into the title and escrow business — two ancillary service lines that could boost its earnings as it works toward profitability. On Monday, the residential firm said it signed a definitive agreement to buy Modus, a title and escrow startup that’s …
See Original Article

(Bristol-Myers Squibb) Bristol Myers Squibb’s Opdivo-Yervoy combo won FDA approval in first-line mesothelioma, just as it failed to top solo Opdivo in preventing cancer recurrence in post-surgery late-stage melanoma. (Bristol Myers Squibb). Share Facebook …
See Original Article

Shares of iQIYI (IQ) – Get Report rose Monday after the Chinese online entertainment company said an internal review had refuted a short seller’s allegations that it inflated revenue and user numbers. It also said it will continue to cooperate with a Securities …
See Original Article

(Reuters) – Bristol Myers Squibb Co said on Monday it would buy MyoKardia Inc for about $13 billion to bolster its portfolio of heart disease treatments, ahead of the potential loss of sales exclusivity of some of its blockbuster drugs. The logo of U.S. drugmaker …
See Original Article

YOUNGSTOWN, Ohio – A spokesman for the Cafaro Co. says the company was still in discussions with Mercy Health-Youngstown to develop a new medical campus at Enterprise Park in Howland, despite Mercy’s announcement Monday that it intends to …
See Original Article